- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
FAD.2: 27 residues within 4Å:- Chain A: N.44, A.46, Q.48, E.49, K.84, Y.190, R.206, Q.207, Y.208, S.209, S.222, V.223, K.224, E.226, Q.231, P.232, P.233, G.234, Y.235, V.236, S.237, V.276, T.279, E.394, V.395, F.396, G.397
20 PLIP interactions:20 interactions with chain A- Hydrophobic interactions: A:Y.190, A:Q.207, A:F.396, A:F.396
- Hydrogen bonds: A:N.44, A:Q.48, A:E.49, A:Q.207, A:Q.207, A:S.209, A:S.222, A:K.224, A:Y.235, A:V.236, A:S.237, A:T.279
- Salt bridges: A:R.206, A:R.206
- pi-Stacking: A:Y.208, A:F.396
FAD.7: 26 residues within 4Å:- Chain B: N.44, A.46, E.49, Q.50, K.84, Y.190, R.206, Q.207, Y.208, S.209, S.222, V.223, K.224, E.226, Q.231, P.232, G.234, Y.235, V.236, S.237, V.276, T.279, E.394, V.395, F.396, G.397
23 PLIP interactions:23 interactions with chain B- Hydrophobic interactions: B:Y.190, B:Q.207, B:F.396
- Hydrogen bonds: B:N.44, B:Q.50, B:Q.207, B:Q.207, B:Y.208, B:S.209, B:S.222, B:K.224, B:E.226, B:P.232, B:Y.235, B:V.236, B:S.237, B:T.279
- Water bridges: B:E.226
- Salt bridges: B:R.206, B:R.206
- pi-Stacking: B:Y.208, B:F.396, B:F.396
- 2 x DGG: 1-[GLYCEROLYLPHOSPHONYL]-2-[8-(2-HEXYL-CYCLOPROPYL)-OCTANAL-1-YL]-3-[HEXADECANAL-1-YL]-GLYCEROL(Non-covalent)
DGG.3: 12 residues within 4Å:- Chain A: A.60, A.63, Y.64, N.67, S.73, L.74, V.77, I.81, W.122, L.129
- Ligands: HEM.1, ECN.5
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:N.67, A:V.77, A:V.77, A:I.81, A:W.122
- Hydrogen bonds: A:N.67
- Water bridges: A:N.67
DGG.8: 16 residues within 4Å:- Chain B: A.60, V.61, A.63, Y.64, E.66, N.67, V.77, I.81, W.122, A.125, Y.126, L.129, L.400, E.403
- Ligands: HEM.6, ECN.9
11 PLIP interactions:11 interactions with chain B- Hydrophobic interactions: B:V.61, B:A.63, B:Y.64, B:Y.64, B:V.77, B:V.77, B:V.77, B:I.81, B:W.122, B:A.125, B:L.400
- 1 x PO4: PHOSPHATE ION(Non-functional Binders)
- 2 x ECN: 1-[(2S)-2-[(4-CHLOROBENZYL)OXY]-2-(2,4-DICHLOROPHENYL)ETHYL]-1H-IMIDAZOLE(Non-covalent)
ECN.5: 12 residues within 4Å:- Chain A: I.24, I.25, F.28, Y.29, F.43, Q.53, A.56, L.57, L.102, I.106
- Ligands: HEM.1, DGG.3
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:L.57, A:L.102, A:L.102
ECN.9: 12 residues within 4Å:- Chain B: I.24, I.25, F.28, Y.29, F.43, Q.53, A.56, L.57, L.102, A.105
- Ligands: HEM.6, DGG.8
7 PLIP interactions:7 interactions with chain B- Hydrophobic interactions: B:I.24, B:L.57, B:L.57, B:L.102, B:L.102
- pi-Stacking: B:F.28
- Halogen bonds: B:I.24
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- El Hammi, E. et al., Structure of Ralstonia eutropha Flavohemoglobin in Complex with Three Antibiotic Azole Compounds. Biochemistry (2011)
- Release Date
- 2011-03-16
- Peptides
- Flavohemoglobin: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
- 2 x DGG: 1-[GLYCEROLYLPHOSPHONYL]-2-[8-(2-HEXYL-CYCLOPROPYL)-OCTANAL-1-YL]-3-[HEXADECANAL-1-YL]-GLYCEROL(Non-covalent)
- 1 x PO4: PHOSPHATE ION(Non-functional Binders)
- 2 x ECN: 1-[(2S)-2-[(4-CHLOROBENZYL)OXY]-2-(2,4-DICHLOROPHENYL)ETHYL]-1H-IMIDAZOLE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- El Hammi, E. et al., Structure of Ralstonia eutropha Flavohemoglobin in Complex with Three Antibiotic Azole Compounds. Biochemistry (2011)
- Release Date
- 2011-03-16
- Peptides
- Flavohemoglobin: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B